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ORIGINAL ARTICLE
Effect of a Smoking Ban on Respiratory Health in Nonsmoking
Hospitality Workers
A Prospective Cohort Study
Sarah Rajkumar, PhD, Daiana Stolz, MD, MPH, Ju¨rg Hammer, MD, Alexander Moeller, MD,
Georg F. Bauer, MD, DrPH, Cong Khanh Huynh, PhD, and Martin Ro¨o¨sli, PhD
Objective: The aim of this study was to examine the effect of a smoking ban
on lung function, fractional exhaled nitric oxide, and respiratory symptoms
in nonsmoking hospitality workers. Methods: Secondhand smoke exposure
at the workplace, spirometry, and fractional exhaled nitric oxide were mea-
sured in 92 nonsmoking hospitality workers before as well as twice after a
smoking ban. Results: At baseline, secondhand smoke-exposed hospitality
workers had lung function values significantly below the population aver-
age. After the smoking ban, the covariate-adjusted odds ratio for cough was
0.59 (95% confidence interval, 0.36 to 0.93) and for chronic bronchitis 0.75
(95% confidence interval, 0.55 to 1.02) compared with the preban period.
Conclusions: The below-average lung function before the smoking ban in-
dicates chronic damages from long-term exposure. Respiratory symptoms
such as cough decreased within 12 months after the ban.
I t has been established that both active and passive smoking areclosely linked to progressive lung function decline.1,2 Cross-
sectional studies have observed significantly higher prevalences
for respiratory symptoms such as cold, cough, phlegm, and throat
problems in persons exposed to secondhand smoke (SHS) at the
workplace.3–6 In the last decades, smoking bans for public places
including hospitality venues were implemented in many countries
all over the world, and potential benefits on respiratory health were
evaluated. Several longitudinal studies examined self-reported respi-
ratory symptoms and lung function before and after a smoking ban.
Some researchers found less respiratory symptoms in both nonsmok-
ers and smokers7,8 and could show that this reduction did not occur
in the control group.8,9 Although respiratory symptoms are very
consistently reported as declining,7,8,10,11 findings on lung function
outcomes are more variable. Two studies in bar workers reported
significant improvements in forced vital capacity (FVC), but not
in forced expiratory volume in 1 second (FEV1) or forced expira-
tory flow between 25% to 75% (FEF25%–75%) after 2 months10 or
1 year12 of smoking ban introduction. A study from the French part
of Switzerland also observed significant improvements in FVC,most
pronounced in women, nonsmokers, and persons above 35 years.13
Conversely, another study found a significant increase in FEV1 in
From the Swiss Tropical and Public Health Institute (Drs Rajkumar and Ro¨o¨sli),
and University of Basel (Drs Rajkumar and Ro¨o¨sli); Clinic of Pulmonary
Medicine and Respiratory Cell Research (Dr Stolz), University Hospital
Basel; Department of Paediatric Pulmonology and Intensive Care Medicine
(Dr Hammer), UKBB, Basel; Department of Respiratory Medicine (Dr
Moeller), University Children’s Hospital; Institute of Social and Preventive
Medicine (Dr Bauer), University of Zu¨rich and Center for Organizational and
Occupational Sciences, ETH Zurich; and Institute for Work and Health (Dr
Huynh), Lausanne, Switzerland.
This work was supported by the Swiss Tobacco Prevention Fund (grant number
09.002032).
The authors declare no conflicts of interest.
Address correspondence to: Martin Ro¨o¨sli, PhD, Socinstrasse 57, 4051 Basel,
Switzerland (martin.roosli@unibas.ch).
Copyright C© 2014 by American College of Occupational and Environmental
Medicine
DOI: 10.1097/JOM.0000000000000262
healthy and asthmatic bar workers within 1 month after ban imple-
mentation but did not report any findings on FVC or FEF25%–75%.11
A Swedish study did not observe any noteworthy improvements in
lung function parameters after the smoking ban.14 A recent Swiss
study reported a significant decrease in hospital admission for acute
exacerbation of chronic obstructive pulmonary disease after a smok-
ing ban but no changes for asthma or pneumonia.15
Fractional exhaled nitric oxide (FeNO) is a marker of airway
inflammation that has been increasingly studied in the past 20 years.16
Measurement of FeNO is noninvasive and highly reproducible and
can easily be performed on-line or off-line.17 It has primarily been
used to investigate and monitor asthma. Allergen exposure upregu-
lates inducible NO synthase in the airway epithelial cells.16 Cigarette
smoke is believed to downregulate inducible NO synthase via a po-
tential negative feedback mechanism.18 Decreased FeNO levels have
been observed in smoking asthma groups19 as well as in nonatopic
smokers20 and rise after smoking cessation.21 The same mechanisms
might reduce FeNO levels when being exposed to SHS. Neverthe-
less, empirical data are scarce and ambiguous. Although one study
found decreased FeNO levels in nonsmokers exposed to SHS,22
several studies reported the opposite in young children exposed to
parental smoking.23,24 This is the first study to look at the effects
of SHS exposure elimination at the workplace on FeNO levels in
nonsmokers.
The implementation of a national smoking ban in Switzerland
in May 2010 was used to set up a prospective, longitudinal study of
nonsmoking hospitality workers in three cantons: Zurich, Basel City,
and Basel County. The two aims of the study were (1) to compare
baseline spirometry values of SHS-exposed hospitality workers with
reference values from the literature and (2) to directly relate work-
place SHS exposure in nonsmoking hospitality workers before and
6 to 12 months after a smoking ban to their respiratory health.
METHODS
Study Population
The study population consisted of 92 participants in total:
62 nonsmoking hospitality workers who had worked for at least
1 year in venues where smoking was either partially or completely
allowed before the introduction of the smoking ban, 14 nonsmoking
hospitality workers who worked in a smoke-free environment at
baseline, and 16 nonsmokers who were regularly exposed to SHS
without being employed in the hospitality sector. These additional 16
nonsmokers were recruited to enlarge the sample size. All hospitality
workers worked in a hospitality venue in one of the study cantons.
Data were collected between March 2010 and December 2011.
To recruit hospitality workers, a list of hospitality venues in
the cantons of Zurich, Basel City, and Basel County was created
using the digital Swiss phonebook from 2009. Each venue received
a letter containing information about the study, with a request to
distribute screening questionnaires to staff serving at tables or at the
bar (waiting staff) and for air measurements to be performed by the
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study team. These letters were followed by phone calls and visits 2
weeks later.
Screening questionnaires were distributed to the waiting staff,
to provide information on the eligibility criteria, which were being
between 18 and 65 years of age, working at least half-time, having
worked for at least 1 year in the hospitality sector, and having been
a nonsmoker for at least 5 years. Eligible study participants were
invited to a health examination, which was carried out in one of the
two study centers in Basel City and Zurich.
The nonhospitality workers were recruited by means of an
online advertisement looking for nonsmokers who were exposed to
SHS on a regular basis, either privately or at work.
Health Examinations
Ethical approvalwas obtained from theEKBB (ethics commit-
tee of both cantons of Basel), and all participants signed an informed
consent form before every examination (Ref. No. EK 317/09).
A baseline examination was conducted within the 3 months
before the introduction of the smoking ban. Subsequently, all study
participants who were exposed to SHS at baseline were invited for
two follow-up examinations at 3 to 6 months and 9 to 12 months
after the smoking ban introduction.
The health examinations comprised cardiovascular and respi-
ratory tests. Spirometry tests were performed using a portable Easy-
One spirometer from ndd Medical Technologies (Andover, MA) and
read out with the EasyWare software. Each participant had to wear
a nose clip and was required to perform three successful measure-
ments within a maximum of eight trials according to the American
Thoracic Society guidelines.25 For FVC and FEV1, the single high-
est value of all tests was used for analysis; for FEF25%–75% and
the FEV1/FVC ratio, the value from the best test (FVC + FEV1 =
maximum) was taken.
Fractional exhaled nitric oxide measurements were per-
formed with a pressure-controlled SIEVERS NOA 280 off-line
kit (GE Power&Water, Boulder, CO) using a Mylar bag (FMI
GmbH, Seeheim, Germany) to collect the exhaled breath follow-
ing the American Thoracic Society/European Respiratory Society
recommendations.26 Participants were asked to inhale through a
mouthpiece attached to an NO-scrubber and then exhale against
a set expiratory resistance maintaining a constant pressure of 12
to 16 mbar without wearing a mouthpiece. The constant pressure
was achieved by visual feedback from an inline pressure gauge. The
pressure range allowed maintaining a constant expiratory flow of
50 mL/s. After 5 seconds, the expiratory air was collected into
a Mylar bag R© until the bag was full. Ambient air was pumped
into an additional bag to check for exceeding levels of ambient
FeNO. The FeNO content was measured within 12 hours with an
EcoMedics CLD 88 analyzer (EcoMedics, Duernten, Switzerland)
using Spiroware 30.0 (ndd Medical Technologies, Andover, MA).
For data analysis the average of the two personal measurements was
used.
Participants were defined as asthma groups if they reported
having suffered fromasthma at an adult age.Asthmagroups currently
on inhaled corticosteroidswere excluded from the analysis as inhaled
corticosteroids decrease FeNO levels (four baseline and six follow-
up observations). A skin prick test at baseline comparing the sixmost
common allergens—birch, mixed grasses, alternaria, mugwort, cat
hair, and dermatophagoides—with a positive and a negative control
was performed in each participant at baseline. Test solutions were
obtained from Trimedal in Dietlikon, Switzerland. Participants were
considered sensitized if they showed a minimal wheal size of 3 mm
to at least one tested allergen.
Interviews
Respiratory and allergy symptoms were assessed during
the health examinations in a computer-based interview adapted
from a standardized questionnaire previously evaluated in the
Swiss population.27 We asked about respiratory and allergy symp-
toms in the last 3 to 12 months. Asthmatic symptoms were
defined as breathlessness, wheezing, or chest tightness. A person
was considered to have chronic bronchitis if he or she stated to suf-
fer from cough or phlegm.27 Participants were counted as positive
for hay fever if they had suffered from symptoms in the present
or previous years. Rhinitis was defined as sneezing and a running
nose during the past 12 months without having a cold or influenza.
Eczema was considered to be present if participants had ever had an
itchy skin rash in areas typical for eczema.
Exposure Measurements
Secondhand smoke was objectively measured using newly
developed Monitor of Nicotine (MoNIC) passive sampling badges
as previously described.28 MoNIC badges are glass fiber filters that
are washed with distilled water, methanol, and CH2Cl2, impregnated
with 5-mg sodium bisulphate per filter, and placed in an airtight
plastic case. Badges were always transported between study centers,
participants, and the laboratory in these airtight cases. The amount
of nicotine on the badge was determined by gas chromatography and
used to calculate the number of passively cigarette equivalents per
day (CE/d) assuming a nicotine content of 0.2 mg per cigarette and
an average ventilation rate of 10 L/min.13,29
In the hospitality venues that agreed to participate, at least one
MoNIC badge was placed for 1 week, near the bar where waiting
personnel spend much of their working time (hereafter referred to as
“workplace badge”). We calculated a time-weighted average work-
place exposure28 for each hospitality worker by multiplying their
average workplace concentration by their workload (in percentage
of full-time equivalent) and by 0.6, which represents time present at
the workplace, includes holidays and considers the fact that nicotine
levels decrease when a venue is unattended.28 For nonhospitality
workers, average SHS exposure was obtained from a personal badge
that participants wore on themselves on a typical day.
Data Analysis
To estimate the long-term consequences of working in SHS-
exposed hospitality venues on lung function, we calculated for each
study participant, who was exposed to SHS at baseline, age, sex, and
height-adjusted percentage FEV1, and FVC values from reference
values for a nonsmoking Swiss population sample.30
By considering the within-subject correlation, mixed linear
random-intercept regression models were used to relate respiratory
parameters to workplace SHS exposure at the time of each health
examination (baseline and follow-ups). Lung function models were
calculated adjusting for age, sex, height, body mass index (linear),
asthma (binary), season (cosine function), and device number (cat-
egorical). FeNO levels were log-transformed and back-transformed
model coefficients are reported. FeNO models were adjusted for
age, sex, allergy (binary), season (cosine function), and time of day
(cosine function). The cosine function for time of day variations
assigned the value of 0 to 12 PM and 1 to 12 AM and for seasonal
variations the value of 0 to July 1 and 1 to January 1. Respiratory
symptoms were evaluated by means of generalized estimating equa-
tion regression models adjusted for age, sex, season, and systolic
blood pressure.
Data were analyzed using Stata 10.1 and Stata 12.0 (StataCorp
LP, College Station, TX).
RESULTS
This study sample comprised 92 participants (Table 1) with no
one suffering from chronic obstructive pulmonary disease. Thereof
23 individuals were exposed throughout the study, 55 were only
exposed at baseline, but not anymore at follow-up and 14 were never
exposed. At baseline average exposure of the 14 study participants
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TABLE 1. Characteristics of the Study Population (n = 92)
Variables Values*
Female sex, n (%) 57 (62)
Age, yrs, n (95% CI) 40.3 (37.6–43.0)
BMI, kg/m2, n (95% CI) 25.6 (24.7–26.5)
Smoking status, n (%)
Never-smokers 67 (72.8)
Ex-smokers 25 (27.2)
Self-reported physical activity,† n (%) 45 (48.9)
Respiratory symptoms, n (%)
Bronchitis symptoms
Cough 27 (29.4)
Phlegm 11 (12.0)
Chronic bronchitis 2 (2.2)
Asthma symptoms 24 (26.1)
Allergy symptoms, n (%)
Hay fever 21 (22.8)
Rhinitis 30 (32.6)
Eczema 6 (6.5)
Comorbidities, n (%)
Self-reported bronchial asthma 13 (14.1)
Allergic‡ 60 (65.2)
Workplace and exposure, n = 76
Average workload, % (95% CI) 92.6 (88.8–96.4)
Type of workplace, n (%)
Bar 7 (9.2)
Cafe´ 18 (23.7)
Restaurant 51 (67.1)
Exposed throughout the study, n (%) 23 (25.0)
Exposed at baseline, not exposed anymore
at follow-up, n (%)
55 (59.8)
Never exposed, n (%) 14 (15.2)
*Values shown are arithmetic means at baseline except where indicated.
†Defined as answered yes to “Do you sweat at least once/week due to physical
activity?”
‡Reacted positively to at least one skin prick test.
BMI, body mass index; CI, confidence interval.
who were never exposed to SHS was 0.1 (95% confidence interval
[CI], 0.0 to 0.2) CE/d, whereas exposure in the 78 SHS-exposed
study participants was 2.4 (95% CI, 1.7 to 3.1) CE/d. Of these 78
participants, 55 were not anymore exposed at follow-up and their
SHS exposure decreased from 2.6 (95% CI: 1.7 to 3.4) CE/d to 0.2
(95% CI: 0.1 to 0.2) CE/d while staying at 1.6 (95% CI, 0.7 to 2.5)
CE/d for the 23 participants who were still exposed at the follow-up
examinations.
From the lung function analyses, 20 observations were ex-
cluded because of insufficient quality (n = 16), technical problems
(n = 1), or insufficient cooperation (n = 3). For FeNO, 10 base-
line and one follow-up measurements had to be excluded from the
analysis because of technical problems.
At baseline, age, sex, and height-specific fitted FVC and FEV1
curves of our sample of nonsmoking SHS-exposed hospitality work-
ers were below the population reference curve30 for most of the age
range in men and women (Fig. 1). The difference was most pro-
nounced for FEV1 in women (Table 2). Nevertheless, longitudinal
exposure-response models did not indicate an association between
lung function parameters and SHS exposure (Table 3). Forced vital
capacity showed a decreasing tendency with increasing exposure,
but this association was not significant. When using exposure mea-
sures from personal badges that took into account private exposure,
no association could be observed either (data not shown).
Average FeNO levels of nonasthmatic study participants were
11.3 (95% CI, 10.3 to 12.5) ppb and of asthmatic study participants
were 14.3 (95% CI, 8.6 to 20.0) ppb. Fractional exhaled nitric ox-
ide was not related to SHS exposure in the longitudinal exposure-
response model (Table 3). Other covariables that were included into
the model such as smoking history, former smoking status, physical
activity, or childhood SHS exposure did not show any association
either and were therefore excluded from the final models. Never-
theless, FeNO values were 36.1% (95% CI, 6.9 to 73.2) higher on
January 1 compared with July 1 (P = 0.01) according to the cosine
seasonality function in the model.
The exposure-response model yielded an odds ratio of 1.25
(95% CI, 1.03 to 1.53) per CE/d increase in SHS exposure for cough
and 1.13 (95% CI, 0.99 to 1.28) for chronic bronchitis (Table 4).
Because the average SHS exposure reduction from the smoking ban
was 2.4 CE/d, these odds ratios translate in a smoking ban odds ratio
of 0.59 (95% CI, 0.36 to 0.93) for cough and 0.75 (95% CI, 0.55
to 1.02) for chronic bronchitis. We found no clear associations for
phlegm and asthma symptoms.
DISCUSSION
In this study population, of SHS-exposed nonsmoking hos-
pitality workers, we observed significantly below-average values of
FVC and FEV1 before implementation of a smoking ban. We found
indications that introducing a smoke-free workplace reduced cough
and chronic bronchitis but not lung function parameters or FeNO.
In line with other smoking ban studies in hospitality
workers,10–12 below-average lung function was observed in the study
participants who were exposed to SHS at baseline and had worked
under such circumstances for at least 1 year but mostly substantially
longer. On average our participants had worked in an-SHS exposed
environment for 8.5 years, ranging from 1 to 33 years. In women the
reduction of the lung function compared with the reference curve in-
creased with age. For men, this pattern was impeded by one observa-
tion with exceptionally good lung function at high age. This pattern,
although on the basis of few observations, suggests a continuous
degradation of the lung function with increasing exposure time. In
contrast to our hypothesis that lung function would increase during
the study, we did not observe any improvement in lung function 6
to 12 months after the introduction of the smoke-free workplaces.
This corresponds to the findings of a Swedish study looking at 71
smokers and nonsmokers that did not find any significant changes in
spirometry 1 year after implementation of a smoking ban14 but con-
tradicts three other studies that observed significant improvements
in FVC of bar workers after 8 weeks10 to 1 year.12, 13 According to
our exposure-response model, FVC decreased by 0.16 L per daily
cigarette equivalent increase in SHS exposure, which was not statis-
tically significant (P = 0.26) (Table 3).
This nonsignificance could be explained by the relatively
small exposure reduction of 2.40 CE/d on average from before to
after the ban. Low exposure levels may be explained by the fact that
most of this study subjects worked in restaurants that served food.
Our measurements performed in bars yielded much higher SHS
levels, but waiters were mostly active smokers and/or unwilling to
participate in the study. All previous studies reporting significant im-
provements in FVC or FEV1 looked at bar workers who presumably
experienced a sharper decline in exposure.10–12
To the best of our knowledge, this is the first study to prospec-
tivelymeasure the effect of a smoking ban onFeNO.Wehypothesized
that the introduction of smoke-free workplaces would lead to an in-
crease in FeNO as has been observed in a smoking cessation study,21
but we did not observe an association between SHS exposure and
FeNO levels in the exposure-response analysis. Different develop-
ments in heavily and lightly SHS-exposed persons regarding FeNO,
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FIGURE 1. Fitted FVC and FEV1 at baseline for men (n = 23) and women (n = 39) adjusted for age and height in comparison to
reference curves.
TABLE 2. FVC and FEV1 Baseline Measurements of Exposed Participants in Comparison to Reference Values29
All (n = 62) Women (n = 39) Men (n = 23)
FVC (% of reference value) 93.1 (90.2–95.9) 93.3 (89.7–97.0) 92.6 (87.8–97.5)
FEV1 (% of reference value) 92.4 (89.4–95.4) 91.9 (88.2–95.6) 93.2 (87.7–98.6)
FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity.
as proposed by Malinovschi et al31 for heavy and light smokers,
could explain this. The interacting effect of SHS32 and asthma33,34
on FeNO levels is complex and not yet fully understood. In addi-
tion to allergic inflammation, further mechanisms may be involved
in FeNO synthesis as indicated by the higher fluctuation observed
in asthmatic groups in this study. So far only 11% to 30% of the
variance of FeNO levels is explained by anthropometric characteris-
tics compared with spirometry where 60% to 75% of the variation
is explained.16 This is mainly because measurement techniques and
the selected influencing factors differ between studies.
Research on the effect of active smoking on FeNO is fairly
consistent with smokers showing reduced levels.17,21,22 Interestingly,
our observed FeNO values were also at the lower end or even be-
low the range of population-based reference FeNO values that have
been published35,36 although these cover a fairly wide range. Dressel
et al35 measured values with a geometric mean of 19.6 ± 1.92 ppb in
a sample of 897 women with an average age of 34.5 ± 13 years and
a 24.3% smoking prevalence. Matsunaga et al36 reports mean values
of 16.9 (95% CI, 6.5 to 35.0) ppb for a nonsmoking Japanese adult
population of 240. Our observed low levels may be the consequence
of long-term SHS exposure similar to the reduced FeNO levels of
smokers.
We also measured heart rate variability and pulse wave veloc-
ity in the same study and reported these findings elsewhere.37 We
found significant improvements in these cardiovascular parameters
after the smoking ban introduction. This suggests that cardiovascular
indicators react more sensitively within the first 12 months after a
substantial SHS exposure reduction than respiratory markers.
A major asset of this study is the prospective design with
repeated health examinations. The prospective design avoids recall
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TABLE 3. Multivariable Exposure-Response Models
Relating SHS Exposure at the Workplace to Respiratory
Outcomes*
Coefficient—Change/Unit
Increase in Cigarette
Equivalents (95% CI) P Value
FEV1, L/s† 0.04 (−0.28 to 0.37) 0.79
FVC, L† − 0.16 (−0.64 to 0.11) 0.26
FEF25%–75%, L/s† 0.31 (−0.62 to 1.25) 0.51
FEV1/FVC ratio† 0.16 (−0.09 to 0.41) 0.20
FeNO, ppb‡ 0.8 (−2.2 to 3.9) 0.62
*From the lung function analyses, 20 observations were excluded because of
insufficient quality (n = 16), technical problems (n = 1), or insufficient cooperation
(n = 3). For FeNO, 11 measurements had to be excluded from the analysis because of
technical problems.
†Adjusted for age, sex, height, BMI, asthma, season, and device.
‡Adjusted for age, sex, allergy, seasonality, and time of day.
BMI, body mass index; FEF, forced expiratory flow; FeNO, fractional exhaled
nitric oxide; FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity;
SHS, secondhand smoke.
TABLE 4. Multivariable Logistic Regression Models Relating
SHS Exposure at the Workplace to Self-Reported Respiratory
Symptoms*
OR† (95% CI) P Value
Cough 1.25 (1.03–1.53) 0.03
Phlegm 0.98 (0.89–1.09) 0.76
Chronic bronchitis 1.13 (0.99 to 1.28) 0.07
Asthma symptoms 1.11 (0.96 to 1.29) 0.16
*Adjusted for age, sex, season, and systolic blood pressure.
†Per unit increase in cigarette equivalents.
CI, confidence interval; OR, odds ratio; SHS, secondhand smoke.
bias in directly measured parameters—limiting this potential bias to
self-reported respiratory symptoms. A further strength is that expo-
sure data were collected at the same time as the health outcomes. By
using the MoNIC badge, nicotine exposure was directly quantified
without using a surrogate measure such as airborne particulate mat-
ter. A limitation of the study is the small sample size. It was particu-
larly difficult to find SHS-exposed non-smoking hospitality workers,
and we were therefore forced to include some nonhospitality work-
ers. Potential bias from this recruitment strategy was minimized
by carefully checking all relevant confounding factors in the data
analysis.
CONCLUSIONS
In this study sample, of nonsmoking hospitality workers, lung
function was below the average population before implementation
of the smoking ban and did not change within 1 year in relation to
a smoking ban implementation. Nevertheless, we found indications
that cough and chronic bronchitis occurred less frequently after the
smoking ban. These results indicate that damages from SHS to
the respiratory system recover very slowly if at all and emphasize
the need for a comprehensive smoking ban to avoid reduced lung
function in nonsmokers because of SHS at the workplace.
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